Coral Springs, Florida — According to state and local development sources, Lupin Pharmaceuticals plans to invest $250 Million to expand in Coral Springs. The company plans to occupy the new space at 4006 NW 124th Ave in Coral Springs, on or about April 1, 2027. According to the company website Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and womens health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

To learn more about Lupin Pharmaceuticals, visit https://www.lupin.com/

Company Contact:
Christoph Funke, President
239-316-1900

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.